{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:11:33Z","timestamp":1790143893639,"version":"4.0.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High-acuity croup requires prompt airway-directed treatment, but evidence comparing nebulized budesonide with a local institutional off-label nebulized-dexamethasone protocol is limited. This internationally unusual route is distinct from standard oral, intramuscular, or intravenous dexamethasone therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-center retrospective cohort study of children younger than 12 years hospitalized from 1 January 2014 through 31 December 2023. Pretreatment severity was fixed at the first institution-defined Grade III assessment. We compared initial nebulized budesonide with the local off-label nebulized-dexamethasone protocol among children receiving epinephrine within a prespecified \u00b115-minute treatment window; corticosteroid administration was time zero. The primary outcome was time to documented resolution of stridor at rest. Stabilized inverse probability of treatment weighting (IPTW) was winsorized at the 1st and 99th percentiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 12,480 all-grade croup presentation events, 452 charts underwent full review and 342 met institution-defined Grade III criteria. Three hundred children met all eligibility criteria (150 per strategy); 264 (88.0%) had institution-defined Grade III documented at the first assessment at our center, 36 (12.0%) progressed from Grade II after arrival, and 84 (28.0%) were interhospital transfers. The IPTW-adjusted difference in time to documented stridor resolution was \u22122.26\u2005h (95% CI \u22122.63 to \u22121.89). Intensive care unit transfer occurred in 4\/150 versus 6\/150 children and intubation in 0\/150 versus 1\/150; these rare events do not establish equivalent safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Initial nebulized budesonide was associated with faster documented recovery than the local off-label nebulized-dexamethasone protocol after adjustment for measured pretreatment variables. This comparison does not address standard oral, intramuscular, or intravenous dexamethasone therapy and should be interpreted as an adjusted observational association.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1948559","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:50:27Z","timestamp":1790142627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Initial nebulized budesonide versus a local off-label nebulized dexamethasone protocol in children with institution-defined grade III croup receiving epinephrine: a retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Yixian","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Jiangxi Provincial Children\u2019s Hospital","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvping","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Jiangxi Provincial Children\u2019s Hospital","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Jiangxi Provincial Children\u2019s Hospital","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0140-6736(08)60170-1","article-title":"Croup","volume":"371","author":"Bjornson","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"CD001955","DOI":"10.1002\/14651858.CD001955.pub5","article-title":"Glucocorticoids for croup in children","volume":"1","author":"Aregbesola","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.279.20.1629","article-title":"Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial","volume":"279","author":"Klassen","year":"1998","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1056\/NEJM199808203390802","article-title":"A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup","volume":"339","author":"Johnson","year":"1998","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ppul.1950200604","article-title":"Oral and inhaled steroids in croup: a randomized, placebo-controlled trial","volume":"20","author":"Geelhoed","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/archpedi.155.12.1340","article-title":"Effectiveness of oral or nebulized dexamethasone for children with mild croup","volume":"155","author":"Luria","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e20183772","DOI":"10.1542\/peds.2018-3772","article-title":"Prednisolone versus dexamethasone for croup: a randomized controlled trial","volume":"144","author":"Parker","year":"2019","journal-title":"Pediatrics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1542\/hpeds.2022-006567","article-title":"Comparative effectiveness of dexamethasone versus prednisone in children hospitalized with acute croup","volume":"12","author":"Jiang","year":"2022","journal-title":"Hosp Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jhm.13542","article-title":"Dexamethasone regime and clinical outcomes in children hospitalized with croup: a cohort study","volume":"20","author":"D'Arienzo","year":"2025","journal-title":"J Hosp Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/pch\/pxx019","article-title":"Acute management of croup in the emergency department","volume":"22","author":"Ortiz-Alvarez","year":"2017","journal-title":"Paediatr Child Health"},{"key":"B11","volume-title":"Clinical Practice Guidelines: Croup (Laryngotracheobronchitis)","year":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using observational routinely-collected health data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"B14","volume-title":"Pediatrics","author":"Wang","year":"2018"},{"key":"B15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1001\/archpedi.1978.02120300044008","article-title":"Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study","volume":"132","author":"Westley","year":"1978","journal-title":"Am J Dis Child"},{"key":"B16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.annemergmed.2014.03.025","article-title":"Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies","volume":"64","author":"Kaji","year":"2014","journal-title":"Ann Emerg Med"},{"key":"B17","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e067975","DOI":"10.1136\/bmj-2021-067975","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"376","author":"Husereau","year":"2022","journal-title":"Br Med J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"l5657","DOI":"10.1136\/bmj.l5657","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/aje\/kwy201","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2022","journal-title":"Clin Kidney J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e006065","DOI":"10.1161\/CIRCOUTCOMES.119.006065","article-title":"Doubly robust estimation of causal effect: upping the odds of getting the right answers","volume":"13","author":"Li","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1948559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:50:29Z","timestamp":1790142629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1948559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":24,"alternative-id":["10.3389\/fped.2026.1948559"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1948559","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1948559"}}